Page 118 - 2023 SMOG Digital
P. 118

ADENOSINE              Lactation Yes (Caution)   Trade Name: Adenocard®
          Class / Mechanism of Action
          Antiarrhythmic Agent
          Slows conduction time through the AV node, inhibits re-entry pathways through the AV node, restoring
          normal sinus rhythm. The half-life of under 10 seconds allows for rapid repeat dosing.
          Indications
          Labeled Indications: Paroxysmal supraventricular tachycardia (PSVT) when clinically advisable, vagal
          maneuvers should be attempted first; not effective for conversion of atrial fibrillation, atrial flutter, or
          ventricular tachycardia.
          Unlabeled: ALS/PALS Guidelines (2020): Stable, narrow-complex regular tachycardias; unstable narrow-
          complex regular tachycardias while preparations are made for synchronized direct-current cardioversion;
          stable regular monomorphic, wide-complex tachycardia as a therapeutic (if SVT) and diagnostic
          maneuver.
          Contraindications
          •  Hypersensitivity to adenosine or any component of the formulation
          •  Second- or third-degree AV block, sick sinus syndrome, or symptomatic bradycardia (except in
            patients with a functioning artificial pacemaker)
          •  Use in patients with atrial fibrillation/flutter with underlying Wolff-Parkinson-White (WPW) syndrome
            (Fuster, 2006); asthma (ALS, 2020)
          •  Known or suspected bronchoconstrictive (Asthma) or bronchospastic lung disease.
          Adverse Reactions / Precautions
          •  May cause transient asystole and new arrhythmia after cardioversion (PACs, AF, PVCs) chest
            discomfort
          •  Headache, Dizziness, Flushing, GI upset
          •  Dyspnea, Bronchospasm in asthmatics
          Dose and Administration:    ADULT    PEDIATRIC Always Reference BROSELOW Tape
          Paroxysmal supraventricular tachycardia:   Paroxysmal supraventricular tachycardia:
          I.V. (rapid push, over 1-2 seconds, via proximal  IV/IO as close to core as possible (rapid push, over
          peripheral line (forearm or above, large bore).  1-2sec,  see  Note):  Follow  each  dose  with
          •  Initial:6mg; if not effective within 1-2min,   10-20mL normal saline flush..
            12mg may be given if needed (maximum
            single dose: 12mg).          •  Initial: 0.1mg/kg (maximum initial dose: 6mg);
                                           if not effective within 1-2min, administer 0.2mg/
                                           kg (maximum single dose: 12mg). Follow
          Notes): Follow each dose with 20mL normal saline   each dose with 5-10mL normal saline flush.
          flush.
          Note: Initial dose of adenosine should be reduced to
          3mg if patient is currently receiving carbamazepine
          or dipyridamole, has a transplanted heart or if
          adenosine is administered via central line (ALS,
          2020).
          Note: Adenosine effects are antagonized by
          caffeine and theophylline, and patients may require
          higher doses.






        118
   113   114   115   116   117   118   119   120   121   122   123